• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2014至2021年中国非传染性疾病防控政策实施情况分析]

[Analysis of non-communicable disease prevention and control policy implementation in China from 2014 to 2021].

作者信息

Wang X K, Li H, Guo J H, Zhang R Y, Cui F Y, Dong W L

机构信息

Chinese Center for Disease Control and Prevention of Chronic Non-communicable Diseases, Beijing 100050, China.

School of Public Health, Shandong University, Jinan 250012, China.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Mar 6;59(3):328-335. doi: 10.3760/cma.j.cn112150-20241024-00845.

DOI:10.3760/cma.j.cn112150-20241024-00845
PMID:40107783
Abstract

This study utilized data from the non-communicable diseases (NCDs) Progress Monitor Reports (2015, 2017, 2020, 2022) released by World Health Organization (WHO) to analyze the implementation of NCDs prevention and control policies in China from 2014 to 2021 through descriptive statistical method, aiming to provide evidence for strengthening national NCDs strategies. The analysis focuses on WHO-recommended 'best buys' policies for NCDs prevention and control, covering 10 categories (18 interventions): national NCDs targets, mortality data, risk factor surveys, national integrated NCDs policies/strategies/action plans, tobacco demand-reduction measures, harmful use of alcohol reduction measures, unhealthy diet reduction policies, physical activity campaigns, national clinical guidelines for cancer/CVD/diabetes/CRD management, and drug therapy/counselling for cardiovascular diseases. In accordance with the WHO's NCDs progress monitor scoring methodology, policies are assigned 1.0 point for full implementation, 0.5 points for partial implementation, and 0 points for non-implementation or missing data, with a maximum total score of 18.0 points. The analytical metrics encompass the policy implementation score, implementation rate, and period-on-period implementation growth rate. The results showed that China's total policy implementation scores for NCDs prevention and control in 2014, 2016, 2019, and 2021 were consistently higher than the global average (8.5, 10.5, 9.5, 9.5 6.7, 8.3, 8.6, 8.6). From 2014 to 2021, the total score increased by 1.0 point, and the implementation rate improved by 8.9%. From 2014 to 2016, China's total policy implementation score rose from 8.5 to 10.5, primarily driven by improvements in tobacco tax increases and unhealthy diet reduction measures (salt reduction, restrictions on high-fat foods, and regulation of breast-milk substitute sales). However, this progress was partially offset by a decline in scores for physical activity campaigns. From 2016 to 2019, the total score decreased to 9.5, largely due to lower scores in harmful use of alcohol reduction measures (alcohol taxation and advertising bans). From 2019 to 2021, the total score remained stable, with increases in marketing to children restrictions balanced by declines in scores for drug therapy/counselling for cardiovascular diseases. In 2021, China's total policy implementation score (9.5) exceeded the global average (8.6) but fell below the G20 average (11.2). Significant gaps remained compared to top-performing G20 countries such as Turkey (16.5), particularly in tobacco control and restrictions on harmful alcohol use. In conclusion, from 2014 to 2021, China's total policy implementation score for NCDs prevention and control consistently exceeded the global average, demonstrating an upward trend, and various NCDs prevention and control policies have been continuously improved.

摘要

本研究利用世界卫生组织(WHO)发布的非传染性疾病(NCDs)进展监测报告(2015年、2017年、2020年、2022年)中的数据,通过描述性统计方法分析了2014年至2021年中国非传染性疾病防控政策的实施情况,旨在为加强国家非传染性疾病战略提供依据。分析重点关注WHO推荐的非传染性疾病防控“最佳购买”政策,涵盖10个类别(18项干预措施):国家非传染性疾病目标、死亡率数据、风险因素调查、国家非传染性疾病综合政策/战略/行动计划、烟草需求减少措施、有害使用酒精减少措施、不健康饮食减少政策、身体活动运动、癌症/心血管疾病/糖尿病/慢性呼吸道疾病管理的国家临床指南以及心血管疾病的药物治疗/咨询。按照WHO的非传染性疾病进展监测评分方法,政策完全实施得1.0分,部分实施得0.5分,未实施或数据缺失得0分,总分最高为18.0分。分析指标包括政策实施得分、实施率和环比实施增长率。结果显示,中国2014年、2016年、2019年和2021年非传染性疾病防控政策的总实施得分始终高于全球平均水平(8.5、10.5、9.5、9.5对6.7、8.3、8.6、8.6)。2014年至2021年,总分提高了1.0分,实施率提高了8.9%。2014年至2016年,中国政策总实施得分从8.5分提高到10.5分,主要得益于烟草税增加和不健康饮食减少措施(减盐、限制高脂肪食品和规范母乳代用品销售)的改善。然而,这一进展部分被身体活动运动得分的下降所抵消。2016年至2019年,总分降至9.5分,主要是由于有害使用酒精减少措施(酒精征税和广告禁令)得分较低。2019年至2021年,总分保持稳定,针对儿童营销限制得分增加,而心血管疾病药物治疗/咨询得分下降,两者相互抵消。2021年,中国政策总实施得分(9.5分)超过全球平均水平(8.6分),但低于二十国集团(G20)平均水平(11.2分)。与土耳其等表现最佳的G20国家(16.5分)相比,仍存在显著差距,尤其是在烟草控制和有害酒精使用限制方面。总之,2014年至2021年,中国非传染性疾病防控政策总实施得分始终超过全球平均水平,呈上升趋势,各项非传染性疾病防控政策不断完善。

相似文献

1
[Analysis of non-communicable disease prevention and control policy implementation in China from 2014 to 2021].[2014至2021年中国非传染性疾病防控政策实施情况分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Mar 6;59(3):328-335. doi: 10.3760/cma.j.cn112150-20241024-00845.
2
Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.2014 年至 2021 年期间非传染性疾病政策的实施情况:对 194 个国家全球政策数据的重复横断面分析。
Lancet Glob Health. 2023 Apr;11(4):e525-e533. doi: 10.1016/S2214-109X(23)00042-6.
3
Implementation of national policies and interventions (WHO Best Buys) for non-communicable disease prevention and control in Ghana: a mixed methods analysis.加纳实施非传染性疾病预防和控制的国家政策和干预措施(世卫组织最佳购买):混合方法分析。
Health Res Policy Syst. 2024 Nov 15;22(1):154. doi: 10.1186/s12961-024-01242-3.
4
Mapping research evidence on implementation of the WHO 'best buys' and other interventions for the prevention and control of non-communicable diseases in sub-Saharan Africa: a scoping review protocol.绘制研究证据图:在撒哈拉以南非洲实施世界卫生组织“最佳购买”和其他干预措施以预防和控制非传染性疾病:范围综述方案。
Syst Rev. 2022 Jun 13;11(1):120. doi: 10.1186/s13643-022-01992-7.
5
Non-communicable diseases in the WHO African region: analysis of risk factors, mortality, and responses based on WHO data.世界卫生组织非洲区域的非传染性疾病:基于世界卫生组织数据的风险因素、死亡率及应对措施分析
Sci Rep. 2025 Apr 10;15(1):12288. doi: 10.1038/s41598-025-97180-3.
6
The state of diet-related NCD policies in Afghanistan, Bangladesh, Nepal, Pakistan, Tunisia and Vietnam: a comparative assessment that introduces a 'policy cube' approach.阿富汗、孟加拉国、尼泊尔、巴基斯坦、突尼斯和越南与饮食相关的非传染性疾病政策现状:引入“政策魔方”方法的比较评估。
Health Policy Plan. 2020 Jun 1;35(5):503-521. doi: 10.1093/heapol/czz175.
7
Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries.实施非传染性疾病政策:对 151 个国家的地缘政治分析。
Lancet Glob Health. 2020 Jan;8(1):e50-e58. doi: 10.1016/S2214-109X(19)30446-2. Epub 2019 Dec 5.
8
Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.对伊朗预防和控制非传染性疾病的世界卫生组织“最佳采购”及其他推荐干预措施的评估与优先排序。
BMC Public Health. 2020 Mar 14;20(1):333. doi: 10.1186/s12889-020-8446-x.
9
Non-communicable disease prevention policy process in five African countries.五个非洲国家的非传染性疾病预防政策制定过程。
BMC Public Health. 2018 Aug 15;18(Suppl 1):961. doi: 10.1186/s12889-018-5825-7.
10
Barriers and Opportunities for WHO "Best Buys" Non-communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review.从政治经济学角度看世界卫生组织“最佳购买”非传染性疾病政策采用和实施的障碍和机遇:一项复杂性系统评价。
Int J Health Policy Manag. 2024;13:7989. doi: 10.34172/ijhpm.2023.7989. Epub 2024 Feb 4.